gvtcx

MMR vaccine 2024

UK Health Security Agency Published 21 Jul 2023 Contracts Finder

key details

Statuscomplete
Category (CPV) 33651640
Deadline2 Mar 2023
Contract start1 Apr 2024
Contract end31 Mar 2028
Procedureopen
SME suitableNo
OCIDocds-b5fd17-5c7fb63e-0767-498d-8235-64ff3e28fb36

Award

SupplierValueDateStatus
MERCK SHARP & DOHME (UK) LIMITED £1 16 Jul 2023 active

description

The provision of a vaccine to protect against measles, mumps and rubella, to be used as part of the national childhood immunisation programme.

Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the suppliers.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
21 Jul 2023 Award (award) · 577eb13e-3656-4210-9735-ba9ef70e4563-664855

more from UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.